ASCO Conference Coverage

ASCO Offers Guidelines for Increasing HPV Vaccine Uptake

Oncologists should raise awareness of HPV-related cancers and role of vaccinations

ASCO Endorses European Association of Urology Guideline on Bladder Cancer

Guideline on muscle-invasive and metastatic bladder cancer, with qualifying statements

New Guideline from ASCO Addresses Use of Biomarkers for Early Breast Cancer

A new clinical practice guideline on the appropriate use of tests for breast tumor biomarkers was issued by ASCO.

ASTRO guidelines for endometrial cancer endorsed by ASCO

Qualifications to guidelines include stronger statements in favor of chemotherapy in some cases.

Immunotherapy combination increases progression-free survival (PFS) in advanced melanoma patients

Treating advanced melanoma patients with either a combination of nivolumab and ipilimumab, or nivolumab alone, significantly increases progression-free survival (PFS) when compared with ipilimumab alone.

ASCO: Elotuzumab demonstrates benefit in multiple myeloma

Survival gains observed when elotuzumab was added to treatment.

ASCO: Additional tissue removal reduces further breast cancer surgery

Removing extra tissue can halve the chances of requiring a second surgery in breast cancer.

ASCO: Lymph node surgery not best option for all melanoma patients

For some patients with advanced melanoma, surgical removal of the lymph nodes surrounding their tumor may not be needed.

ASCO: PD-1 immunotherapy beneficial for patients with NSCLC

Fewer side effects, longer survival for nivolumab versus docetaxel seen in patients with non-small-cell lung cancer (NSCLC).

Hepatitis virus variations responsible for variations in liver cancer

Significant clinical variations have been identified among patients with hepatocellular carcinoma (HCC).

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs